SCHEMBL2452199

SCHEMBL2452199

CCCCCCCCCCCCSc1ccc(C(=O)c2ccc(OC)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.54
THRB P10828 1/20 0.54
ALDH1A1 P00352 3/20 0.50
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
PLK1 P53350 3/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
MEN1 O00255 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31500032 0.89 THRB (0.64) THRATHRBPLK1MAPTHPGD
SCHEMBL5315774 0.88 PTGES (0.55) THRATHRBALDH1A1MTNR1AMTNR1B
SCHEMBL7260314 0.88 PTGES (0.55) THRATHRBALDH1A1MTNR1AMTNR1B
SCHEMBL20495338 0.88 PTGES (0.55) THRATHRBALDH1A1MTNR1AMTNR1B
SCHEMBL14838080 0.86 PTGES (0.52) THRATHRBALDH1A1MTNR1AMTNR1B
SCHEMBL21814701 0.84 PLK1 (0.46) THRATHRBALDH1A1PLK1RAB9A
SCHEMBL10870780 0.84 THRB (0.58) THRATHRBALDH1A1PLK1LMNA
SCHEMBL19199548 0.84 THRA (0.58) THRATHRBPLK1SMN1; SMN2LMNA
SCHEMBL10870744 0.84 THRB (0.58) THRATHRBALDH1A1PLK1LMNA
SCHEMBL17264205 0.83 ALDH1A1 (0.53) THRATHRBALDH1A1MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS BASF SE (DE) 2026-05-14 US disclosed
EP-4709544-A1 COMPOSITIONS, COMPRISING SILVER NANOPLATELETS BASF SE (DE) 2026-03-18 EP disclosed
US-12515253-B2 Compositions, comprising silver nanoplatelets BASF SE (DE) 2026-01-06 US disclosed
US-20250263566-A1 CASTING LACQUER FOR SCREEN PRINTING DE LA RUE INTERNATIONAL LIMITED (GB) 2025-08-21 US disclosed
US-12325806-B2 Photocurable composition for use in 3D printing BASF SE (DE) 2025-06-10 US disclosed
US-12296391-B2 Security element BASF SE (DE) 2025-05-13 US disclosed
EP-4337734-B1 COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES BASF SE (DE) 2025-04-23 EP disclosed
US-12208447-B2 Compositions, comprising silver nanoplatelets BASF SE (DE) 2025-01-28 US disclosed
WO-2024231418-A1 COMPOSITIONS, COMPRISING SILVER NANOPLATELETS BASF SE (DE) 2024-11-14 WO disclosed
CN-118891584-A Casting paint for screen printing 巴斯夫欧洲公司 2024-11-01 CN disclosed
US-8993219-B2 Printing diffraction gratings on paper and board BASF SE (DE) 2015-03-31 US disclosed
WO-2014187750-A1 SECURITY ELEMENTS AND METHOD FOR THEIR MANUFACTURE BASF SE (DE) 2014-11-27 WO disclosed
EP-2723576-A1 PRINTING DIFFRACTION GRATINGS ON PAPER AND BOARD BASF SE (DE) 2014-04-30 EP disclosed
US-20140110931-A1 PRINTING DIFFRACTION GRATINGS ON PAPER AND BOARD BASF SE (DE) 2014-04-24 US disclosed
WO-2014041121-A1 SECURITY ELEMENTS AND METHOD FOR THEIR MANUFACTURE BASF SE (DE) 2014-03-20 WO disclosed
WO-2012176126-A1 PRINTING DIFFRACTION GRATINGS ON PAPER AND BOARD BASF SE (DE) 2012-12-27 WO disclosed
EP-2145231-B1 PHOTOACTIVABLE NITROGEN BASES BASF SE (DE) 2011-09-14 EP disclosed
US-20100105794-A1 PHOTOACTIVABLE NITROGEN BASES CIBA CORPORATION (US) 2010-04-29 US disclosed
EP-2145231-A1 PHOTOACTIVABLE NITROGEN BASES BASF SE (DE) 2010-01-20 EP disclosed
WO-2008119688-A1 PHOTOACTIVABLE NITROGEN BASES BASF SE (CH) 2008-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS COPE, COPB2, C9 THRA 2660/4885THRB 2618/4885ALDH1A1 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.